4//SEC Filing
Gregory Philip D 4
Accession 0001562180-24-000365
CIK 0001860782other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:09 PM ET
Size
9.3 KB
Accession
0001562180-24-000365
Insider Transaction Report
Form 4
Gregory Philip D
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-01-05$3.75/sh−795$2,984→ 230,842 total - Award
Stock Option (Right to buy)
2024-01-08+158,875→ 158,875 totalExercise: $3.97Exp: 2034-01-08→ Common Stock (158,875 underlying) - Award
Common Stock
2024-01-08+79,438→ 310,280 total
Footnotes (4)
- [F1]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units ("RSUs").
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.675 to $3.83, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]RSU awards vest over a four-year period at the rate of 25% on 01/02/2025, 25% on 01/02/2026, 25% on 01/02/2027, and 25% on 01/02/2028.
- [F4]This stock option vests over a four-year period at the rate of 25% on 01/02/2025, and then in 36 equal monthly installments thereafter.
Documents
Issuer
2seventy bio, Inc.
CIK 0001860782
Entity typeother
Related Parties
1- filerCIK 0001343543
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:09 PM ET
- Size
- 9.3 KB